Point of Care (POC) Diagnostics Market Size, Share and Industry Analysis By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy and Fertility Testing Products, Hematology Testing Products, Others), By End User (Hospitals Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, Home and Self Testing) and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

                                          
We have updated Point-of-Care Diagnostics Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Point-of-Care Diagnostics market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Point-of-Care Diagnostics market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Point-of-Care Diagnostics Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Point-of-Care Diagnostics Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Point-of-Care Diagnostics Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

  
Abbott
  
Johnson & Johnson Services, Inc.
  
Becton, Dickinson and Company (BD)
  
Quidel Corporation
  
Sekisui Diagnostics
  
Danaher
  
Siemens Healthcare GmbH
  
AccuBioTech Co., Ltd.
  
Chembio Diagnostic Systems, Inc.
  
EKF Diagnostics Holdings plc
  
Instrumentation Laboratory (A Werfen Company)
  
Nova Biomedical
  
PTS Diagnostics

Report Coverage

The increasing demand for rapid diagnostics in the general population is one of the key factors driving the growth of the global point of care testing market. The increasing R&D initiatives in the POC diagnostics market and the recent product launches are also positively contributing to the growth of the market. The report on global market focuses on size in terms of revenue (US$ Mn), of rapid diagnostics, for the period 2015-2026.

The report offers information about various dynamics of the market, including drivers, restraints, opportunities for players in the point-of-care diagnostics market, and trends. The report analyzes and evaluates the current market size, growth rate, and forecast figure of the global market, with regards to the product, which is segmented into the blood glucose monitoring, infectious diseases, cardiometabolic diseases, pregnancy and fertility testing products, hematology testing products, and others. Based on the end-user, the market is categorized into hospital bedside, physicians office lab, urgent care & retail clinics, and home and self-testing.

The report also offers key insights related to an overview of POC diagnostics market (2018) - for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, overview of the number of point-of-care (POC) diagnostics procedures by key countries, overview of price analysis of types of rapid tests, overview of regulatory scenario by key countries, overview of reimbursement scenario by key countries, pipeline analysis, new product launches and key industry developments - mergers, acquisitions, and partnerships and key growth indicators of POC diagnostics market.

SEGMENTATION

By Product

  
Blood Glucose Monitoring
  
Infectious Diseases
  
Cardiometabolic Diseases
  
Pregnancy and Fertility Testing Products
  
Hematology Testing Products
  
Others

By End User

  
Hospitals Bedside
  
Physicians Office Lab
  
Urgent Care & Retail Clinics
  
Home and Self Testing

By Geography

  
North America (U.S., and Canada)
  
Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico, and the Rest of Latin America)
  
Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)

Key Industry Developments

In June 2019, Abbott announced the launch of Afinion HbA1c Dx test, a point of care (POC) diagnostic for the testing of diabetes

In May 2016, Koninklijke Philips N.V. announced the launch of a new handheld blood test called the Minicare I-20 for the rapid point-of-care diagnosis of heart attack